Perioperative safety of Hydrosoft coils
Authors:
- Aquilla S TurkATAquilla S Turk
- Raymond D TurnerRTRaymond D Turner
- 13 September 2011
- journal article
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 4 (5) , 375-378
Abstract
Objective Hydrosoft coils were developed to serve as finishing coils to prevent aneurysmal recurrence at the neck. Initial animal studies were encouraging since some studies showed endothelial healing across the neck without recurrence over time. However, theoretical concerns exist regarding the potential threat to parent vessels as the Hydrosoft coils at the neck expand, as well as whether such coils can be adequately supple to safely serve as a true finishing coil. A retrospective review of the initial clinical experience utilizing Hydrosoft coils from three high-volume centers was performed. Methods Each center was asked to report angiographic (aneurysmal location, aneurysmal maximal size, neck size, incidence of intraprocedural parent vessel thrombosis, coil herniation, aneurysmal rupture as well as Raymond scale and percent occlusion after coiling) and clinical (rupture status, Hunt and Hess grade, incidence of stroke, hemorrhage, vasospasm and hydrocephalus) data on consecutive patients who underwent placement of Hydrosoft coils. Results A total of 141 patients were enrolled. Embolization achieved a Raymond Scale score of I (complete obliteration) in 79 aneurysms (56%), II (residual neck) in 40 aneurysms (28%) and III (residual dome) in 21 aneurysms (15%); in one case the Hydrosoft coil could not be placed. Procedural morbidity and mortality were 2.1% and 1.4%, respectively. No complications were definitively attributed to the use of Hydrosoft coils. There were three cases (2.1%) of parent vessel thrombosis, two of which resolved after intraprocedural administration of thrombolytic agents and did not lead to neurological sequelae. The incidences of intraprocedural or periprocedural aneurysmal rupture (2.1%), cerebral hemorrhage (3.5%), stroke (4.9%), vasospasm (26.2%) or hydrocephalus (31.1%) were comparable to contemporary literature. Conclusion The use of Hydrosoft coils appears to be safe and does not lead to higher complication rates than are currently accepted in the literature. Further prospective studies are required to determine whether the use of Hydrosoft coils results in a lower incidence of aneurysmal recurrence.Keywords
This publication has 29 references indexed in Scilit:
- Hydrogel-coated coils versus bare platinum coils for the endovascular treatment of intracranial aneurysms (HELPS): a randomised controlled trialThe Lancet, 2011
- Short-Term Antifibrinolytic Therapy Before Early Aneurysm Treatment in Subarachnoid Hemorrhage: Effects on Rehemorrhage, Cerebral Ischemia, and HydrocephalusNeurosurgery, 2010
- Comparison of experimental aneurysms embolized with second-generation embolic devices and platinum coilsActa Neurochirurgica, 2009
- Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhageJournal of Neurosurgery, 2008
- Wall enhancement, edema, and hydrocephalus after endovascular coil occlusion of intradural cerebral aneurysmsJournal of Neurosurgery, 2008
- HydroCoil Endovascular Aneurysm Occlusion and Packing Study (HELPS Trial): Procedural Safety and Operator-Assessed Efficacy ResultsAmerican Journal of Neuroradiology, 2008
- Durability of Treatment of Intracranial Aneurysms With Hydrocoils Is Not Different From Standard Platinum CoilsStroke, 2006
- Embolization of Intracranial Aneurysms With Hydrogel-Coated Coils Versus Inert Platinum CoilsStroke, 2006
- Long-Term Angiographic Recurrences After Selective Endovascular Treatment of Aneurysms With Detachable CoilsStroke, 2003
- International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trialThe Lancet, 2002